Serious infections such as endocarditis due to extremely drug-resistance gram-negative bacteria are an increasing challenge. Here, we present successful adjunctive use of cefiderocol for a patient with persistently bacteremic healthcare-associated native aortic valve endocarditis due to an extended-spectrum beta-lactamase-positive Pseudomonas aeruginosa susceptible in vitro only to colistin, following failure of conventional therapeutic options.
|Number of pages||3|
|Journal||Clinical Infectious Diseases|
|Early online date||12 Nov 2018|
|Publication status||Published - 1 Jun 2019|
- Pseudomonas aeruginosa
- drug resistance